Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)
- PMID: 16622123
- PMCID: PMC2094011
- DOI: 10.1093/jnci/djj132
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)
Abstract
Background: Multiparity, young age at first childbirth, and breast-feeding are associated with a reduced risk of breast cancer in the general population. The breast cancer predisposition gene, BRCA1, regulates normal cell differentiation. Because mammary gland cells divide and differentiate during pregnancy, reproductive factors may influence breast cancer risk in BRCA1/2 mutation carriers differently than they do in noncarriers.
Methods: We performed a retrospective cohort study of 1601 women in the International BRCA1/2 Carrier Cohort Study cohort, all of whom carried a mutation in BRCA1 or BRCA2. Information on reproductive factors was obtained from a questionnaire. At the time of interview 853 subjects were classified with breast cancer. Data were analyzed by using a weighted cohort approach. All statistical tests were two-sided.
Results: There was no statistically significant difference in the risk of breast cancer between parous and nulliparous women. Among parous women, an increasing number of full-term pregnancies was associated with a statistically significant decrease in the risk of breast cancer (Ptrend = .008); risk was reduced by 14% (95% confidence interval [CI] = 6% to 22%) for each additional birth. This association was the same for carriers of mutations in either BRCA1 or BRCA2 and was restricted to women older than 40 years. In BRCA2 mutation carriers, first childbirth at later ages was associated with an increased risk of breast cancer compared with first childbirth before age 20 years (20-24 years, hazard ratio [HR] = 2.33 [95% CI = 0.93 to 5.83]; 25-29 years, HR = 2.68 [95% CI = 1.02 to 7.07]; > or = 30 years, HR = 1.97 [95% CI = 0.67 to 5.81]), whereas in BRCA1 mutation carriers, first childbirth at age 30 years or later was associated with a reduced risk of breast cancer compared with first childbirth before age 20 years (HR = 0.58 [95% CI = 0.36 to 0.94]). Neither history of interrupted pregnancies (induced abortions or miscarriage) nor history of breast-feeding was statistically significantly associated with the risk of breast cancer.
Conclusions: BRCA1 and BRCA2 mutation carriers older than 40 years show a similar reduction in breast cancer risk with increasing parity as non-carriers.
Comment in
-
Re: Pregnancies, breastfeeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).J Natl Cancer Inst. 2007 Jul 18;99(14):1130-1; author reply 1131. doi: 10.1093/jnci/djm039. Epub 2007 Jul 10. J Natl Cancer Inst. 2007. PMID: 17623800 No abstract available.
Similar articles
-
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).Breast Cancer Res. 2012 Jul 3;14(4):R99. doi: 10.1186/bcr3218. Breast Cancer Res. 2012. PMID: 22762150 Free PMC article.
-
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.Int J Cancer. 2005 Dec 20;117(6):988-91. doi: 10.1002/ijc.21273. Int J Cancer. 2005. PMID: 15986445
-
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res Treat. 2010 Jan;119(1):221-32. doi: 10.1007/s10549-009-0394-1. Epub 2009 Apr 16. Breast Cancer Res Treat. 2010. PMID: 19370414
-
Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studies.Cancer Epidemiol. 2014 Feb;38(1):1-8. doi: 10.1016/j.canep.2013.11.004. Epub 2013 Dec 12. Cancer Epidemiol. 2014. PMID: 24332935 Review.
-
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.Prostate. 2019 Jun;79(8):880-895. doi: 10.1002/pros.23795. Epub 2019 Mar 22. Prostate. 2019. PMID: 30900310
Cited by
-
Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).Breast Cancer Res. 2012 Jul 3;14(4):R99. doi: 10.1186/bcr3218. Breast Cancer Res. 2012. PMID: 22762150 Free PMC article.
-
JNCI and cancer prevention.J Natl Cancer Inst. 2015 Feb 24;107(3):djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar. J Natl Cancer Inst. 2015. PMID: 25713150 Free PMC article.
-
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations.Eur J Hum Genet. 2011 May;19(5):500-6. doi: 10.1038/ejhg.2010.241. Epub 2011 Jan 26. Eur J Hum Genet. 2011. PMID: 21267012 Free PMC article.
-
A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers.BMC Med Res Methodol. 2021 Jul 29;21(1):155. doi: 10.1186/s12874-021-01299-6. BMC Med Res Methodol. 2021. PMID: 34325649 Free PMC article.
-
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.Oncotarget. 2017 Feb 7;8(6):9144-9154. doi: 10.18632/oncotarget.13423. Oncotarget. 2017. PMID: 27880720 Free PMC article.
References
-
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Press. Lyon: IARC Cancer Base No. 5; 2001.
-
- Ponder BA. Cancer genetics. Nature. 2001;411:336–41. - PubMed